Questioning the cost of convenience: a mixed methods study of the impact of a telehealth service delivery on pharmacists’ work
4 affiliations
- 1Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital
- 2School of Clinical Medicine, Faculty of Medicine and Health, St Vincent’s Healthcare Clinical Campus, University of NSW Sydney
- 3The University of Sydney
- 4Pharmacy Department, St Vincent’s Hospital
Abstract
Objectives Telehealth represents a fundamental change to the health care delivery process. Despite the burgeoning literature on the rapid expansion of telehealth services during the COVID-19 pandemic, the consequences of these changes for clinicians’ workload are seldom examined. This study addresses that gap by describing the interactions between patient activity, work processes and pharmacists’ experience of an Australian hospital outpatient telepharmacy service that was rapidly upscaled during the pandemic to ensure all patients continued to access pharmaceutical care. Methods A three-phase explanatory mixed methods design was used: (1) a retrospective audit quantified changes to patient use of telepharmacy before (August 2019-March 2020) and during (March-September 2020) COVID-19 lockdowns; (2) process mapping to visualise and compare all the work steps involved in delivering telepharmacy and its face-to-face equivalent; (3) interviews with pharmacists (n = 10) to explain the patterns of patient use identified in the audit data and explore the impact of telepharmacy on their work. Results Telepharmacy occasions of service (N = 1442) increased 6-fold during COVID-19 lockdown, with a significant increase in metropolitan and express deliveries. Comparing the process maps reveals the inherent efficiencies of face-to-face care, as remote dispensing involved substantially more administrative steps than in-person encounters. Three themes emerged from the interviews that illuminate pharmacists’ experience of delivering telepharmacy: increased and less satisfying work; shifting responsibility for medication management from patients to pharmacists; and questioning the cost of convenience. Conclusions Telepharmacy successfully maintained access to pharmaceutical care for highly immunocompromised outpatients during, and long after the COVID-19 pandemic, but this came at the cost of increased administrative workload and reduced professional satisfaction for pharmacists. As telehealth becomes embedded in routine care, service models must account for these hidden workload consequences and ensure telehealth is targeted to settings where it delivers value rather than just convenience.
Related
- Barriers and enablers shaping kidney transplant care delivery: Insights from Iraqi pharmacists
- Optimising ovarian cancer care: An embedded mixed methods evaluation of a national nurse-led telehealth program.
- Multiregional characterisation of collaboration between clinical and community-based organisations for postpartum transition care delivery: A mixed methods study protocol.
- Co-development, initial evaluation and implementation of a digital health intervention (SmartADHD) for young people (aged 16-30) with attention deficit hyperactivity disorder, including optimisation for sustainable delivery via health and social care settings: protocol for a mixed-methods study.
- Digital training to support delivery of an evidence-based cardiac rehabilitation programme for heart failure: a mixed-methods evaluation of healthcare professionals' training experiences and intervention fidelity.
BibTeX
@article{carland2026questioning,
title = {{Questioning the cost of convenience: a mixed methods study of the impact of a telehealth service delivery on pharmacists’ work}},
author = {Jane E. Carland and Christine T. Shiner and Vishal Suresh and Terry Melocco and Michelle Le and Sarah Wise},
journal = {BMC Health Services Research},
year = {2026},
month = oct,
doi = {10.1186/s12913-026-15469-z},
url = {https://doi.org/10.1186/s12913-026-15469-z},
note = {CC BY},
}
RIS
TY - JOUR
TI - Questioning the cost of convenience: a mixed methods study of the impact of a telehealth service delivery on pharmacists’ work
AU - Jane E. Carland
AU - Christine T. Shiner
AU - Vishal Suresh
AU - Terry Melocco
AU - Michelle Le
AU - Sarah Wise
PY - 2026
DA - 2026/10/25
JO - BMC Health Services Research
DO - 10.1186/s12913-026-15469-z
UR - https://doi.org/10.1186/s12913-026-15469-z
AB - Objectives Telehealth represents a fundamental change to the health care delivery process. Despite the burgeoning literature on the rapid expansion of telehealth services during the COVID-19 pandemic, the consequences of these changes for clinicians’ workload are seldom examined. This study addresses that gap by describing the interactions between patient activity, work processes and pharmacists’ experience of an Australian hospital outpatient telepharmacy service that was rapidly upscaled during the pandemic to ensure all patients continued to access pharmaceutical care. Methods A three-phase explanatory mixed methods design was used: (1) a retrospective audit quantified changes to patient use of telepharmacy before (August 2019-March 2020) and during (March-September 2020) COVID-19 lockdowns; (2) process mapping to visualise and compare all the work steps involved in delivering telepharmacy and its face-to-face equivalent; (3) interviews with pharmacists (n = 10) to explain the patterns of patient use identified in the audit data and explore the impact of telepharmacy on their work. Results Telepharmacy occasions of service (N = 1442) increased 6-fold during COVID-19 lockdown, with a significant increase in metropolitan and express deliveries. Comparing the process maps reveals the inherent efficiencies of face-to-face care, as remote dispensing involved substantially more administrative steps than in-person encounters. Three themes emerged from the interviews that illuminate pharmacists’ experience of delivering telepharmacy: increased and less satisfying work; shifting responsibility for medication management from patients to pharmacists; and questioning the cost of convenience. Conclusions Telepharmacy successfully maintained access to pharmaceutical care for highly immunocompromised outpatients during, and long after the COVID-19 pandemic, but this came at the cost of increased administrative workload and reduced professional satisfaction for pharmacists. As telehealth becomes embedded in routine care, service models must account for these hidden workload consequences and ensure telehealth is targeted to settings where it delivers value rather than just convenience.
SN - 1472-6963
ER -